SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030193
Filing Date
2021-07-27
Accepted
2021-07-27 20:14:16
Documents
2
Period of Report
2021-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3910
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3265
  Complete submission text file 0000899243-21-030193.txt   8778
Mailing Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010 (212) 551-1600
DA32 Life Science Tech Acquisition Corp. (Issuer) CIK: 0001863294 (see all company filings)

IRS No.: 863352988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010 (212) 551-1600
DA32 Sponsor LLC (Reporting) CIK: 0001871990 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40676 | Film No.: 211119438